Author
Listed:
- Jung-Ah Kang
(Gwangju Institute of Science and Technology)
- Songwon Kim
(Gwangju Institute of Science and Technology)
- Minji Park
(CHA University School of Medicine)
- Hyun-Jin Park
(Gwangju Institute of Science and Technology)
- Jeong-Hyun Kim
(Gwangju Institute of Science and Technology)
- Sanghyeok Park
(Gwangju Institute of Science and Technology)
- Jeong-Ryul Hwang
(Gwangju Institute of Science and Technology)
- Yong-Chul Kim
(Gwangju Institute of Science and Technology)
- Yoon Jun Kim
(Seoul National University College of Medicine)
- Yuri Cho
(CHA University School of Medicine)
- Mi Sun Jin
(Gwangju Institute of Science and Technology)
- Sung-Gyoo Park
(Gwangju Institute of Science and Technology)
Abstract
Chronic hepatitis B virus (HBV) infection can cause cirrhosis and hepatocellular carcinoma and is therefore a serious public health problem. Infected patients are currently treated with nucleoside/nucleotide analogs and interferon α, but this approach is not curative. Here, we screen 978 FDA-approved compounds for their ability to inhibit HBV replication in HBV-expressing HepG2.2.15 cells. We find that ciclopirox, a synthetic antifungal agent, strongly inhibits HBV replication in cells and in mice by blocking HBV capsid assembly. The crystal structure of the HBV core protein and ciclopirox complex reveals a unique binding mode at dimer-dimer interfaces. Ciclopirox synergizes with nucleoside/nucleotide analogs to prevent HBV replication in cells and in a humanized liver mouse model. Therefore, orally-administered ciclopirox may provide a novel opportunity to combat chronic HBV infection by blocking HBV capsid assembly.
Suggested Citation
Jung-Ah Kang & Songwon Kim & Minji Park & Hyun-Jin Park & Jeong-Hyun Kim & Sanghyeok Park & Jeong-Ryul Hwang & Yong-Chul Kim & Yoon Jun Kim & Yuri Cho & Mi Sun Jin & Sung-Gyoo Park, 2019.
"Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10200-5
DOI: 10.1038/s41467-019-10200-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10200-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.